In treatment-naive samples, Mono_EREG exhibited high expression of CCL family genes (CCL3L3, CCL20), EREG, and BCL2A1, which are associated with tumor progression [35,36,37], suggesting functional impairment (Figure 4G, Supplementary Figure S4G). Here, BCL2A1 is linked to neoplasm.